65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03113760 (ClinicalTrials.gov)	July 21, 2017	28/2/2017	Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency	Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial With Tadekinig Alfa (r-hI ...	NLRC4-MAS;XIAP Deficiency	Drug: Tadekinig alfa;Other: 0.9% sodium chloride	AB2 Bio Ltd.	NULL	Recruiting	N/A	N/A	All	10	Phase 3	United States;Canada;Germany